New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
09:05 EDTSTJSt. Jude Medical to acquire NeuroTerm for approximately $200M in cash
St. Jude Medical has signed a definitive agreement to acquire privately held NeuroTherm, a manufacturer of interventional pain management therapies, for approximately $200M in cash. NeuroTherm is involved in the treatment of spinal pain using radiofrequency ablation, a segment of the chronic pain market in which St. Jude Medical does not currently participate. The company expects to complete this transaction by the end of the third quarter, subject to customary closing conditions. NeuroTherm is expected to add approximately $10M-$15M to St. Jude Medicalís 2014 sales. Excluding acquisition-related expenses, this transaction will be neutral to St. Jude Medicalís consolidated EPS in 2014 and accretive thereafter on a GAAP basis.
News For STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 30, 2015
08:03 EDTSTJSt. Jude launches Proclaim Elite in Europe
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical management to meet with Deutsche Bank
Subscribe for More Information
November 19, 2015
08:02 EDTSTJSt. Jude Medical announces FDA approval of Proclaim Elite SCS system
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use